NCT06526091 Cerebral Oxygen Saturation Monitoring During Optimum Cord Management in Preterm Infants
| NCT ID | NCT06526091 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Imperial College Healthcare NHS Trust |
| Condition | Pre-Term |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-02-15 |
| Primary Completion | 2024-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2023-02-15 with a primary completion date of 2024-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will assess the feasibilty measuring cerebral oxygen saturations using a Near Infrared Spectroscopy (NIRS) monitor immediately after delivery of preterm infants. The investigators aim to evaluate the effects of optimum cord management on cerebral oxygenation in this cohort
Eligibility Criteria
Inclusion Criteria: * All babies eligible for optimum cord management born before 34 completed weeks gestational age * Parental consent Exclusion Criteria: * Multiple pregnancies * Infants for whom resuscitation at birth is not appropriate * Antenatal or immediate postnatal diagnosis of severe congenital anomaly * Infants with complex congenital cardiac disease
Contact & Investigator
Jayanta Banerjee, MD (Res)
PRINCIPAL INVESTIGATOR
Imperial College Healthcare NHS Trust
Frequently Asked Questions
Who can join the NCT06526091 clinical trial?
This trial is open to participants of all sexes, aged 1 Minute or older, up to 24 Hours, studying Pre-Term. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06526091 currently recruiting?
Yes, NCT06526091 is actively recruiting participants. Contact the research team at jayanta.banerjee@nhs.net for enrollment information.
Where is the NCT06526091 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT06526091 clinical trial?
NCT06526091 is sponsored by Imperial College Healthcare NHS Trust. The principal investigator is Jayanta Banerjee, MD (Res) at Imperial College Healthcare NHS Trust. The trial plans to enroll 40 participants.